contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-the-presentation-of-bicos-year-end-report-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

BICO Group är verksamt inom bioteknikbranschen och fokuserar på utveckling och tillverkning av teknologier för cellbaserad forskning och medicinsk utveckling. Bolagets produkter riktar sig till forskare och läkemedelsbolag. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. BICO Group grundades 2016 och har sitt huvudkontor i Göteborg.

BICO Group

BICO’s Year-end report 2025 will be published on Wednesday February 18, 2026, at 07:00am CET. Following the release of the report, a telephone conference with the opportunity to ask questions...

<div class="mfn-preamble"><p><strong>BICO’s Year-end report 2025 will be published on Wednesday February 18, 2026, at 07:00am CET. Following the release of the report, a telephone conference with the opportunity to ask questions will be held in English at 10:00 am CET on the same day, with President &amp; CEO Maria Forss and CFO Jacob Thordenberg presenting the year-end report.</strong></p></div><div class="mfn-body"><p>Information about the presentation and webcast<br>The presentation will be available on BICO’s website from 09:00am CET. <br><a rel="noopener" href="https://bico.com/investors/">https://bico.com/investors/</a></p><p>If you wish to participate via webcast, please use the link below: <a rel="noopener" href="https://bico.events.inderes.com/q4-report-2025">https://bico.events.inderes.com/q4-report-2025</a></p><p>If you wish to participate via teleconference, please register via the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via teleconference.&nbsp;<br><a rel="noopener" href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2F%2Fconference.inderes.com%2Fteleconference%2F%3Fid%3D5001346__%3B!!C05lT65P!2RNPid8b-km4ZgDFmsUIlKaepq1AQTgeKDut16Axk4Su9vPbq8pPEs3IVyfoXFsctJrxaBbu3OCyx9uu878%24&amp;data=05|02|igl%40bico.com|d5571574573c4d59c23e08de2e6464f5|92cf905a49bb4c9f8139358aed8b76c8|0|0|638999206053362560|Unknown|TWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D|0|||&amp;sdata=Laso3euPhEmC%2BLqlL8ACyxyJK1vr1IoA28L80TjV%2BC4%3D&amp;reserved=0">https://conference.inderes.com/teleconference/?id=5001346</a></p></div><div class="mfn-footer mfn-3bedbe434cfb"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Jacob Thordenberg, CFO, BICO Group AB<br>Phone: +46 735 34 88 84<br>E-mail:&nbsp;<a rel="noopener" href="mailto:jt@bico.com">jt@bico.com</a></p></div><div class="mfn-footer mfn-f3d84de701a0"><p><em>The information was submitted for publication, through the agency of the contact persons set out above on February 4, 2026, at 7am CET.</em></p></div><div class="mfn-footer mfn-31d379c491ca"><p><strong class="mfn-heading-1">About BICO</strong><br><a rel="noopener" href="https://bico.com/">BICO</a> is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 10,900 publications. Operating through two business areas – Lab Automation and Life Science Solutions – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. <a rel="noopener" href="http://www.bico.com">www.bico.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/a7c05711-2cd4-4e36-93bc-b1bf78ea4a1a/invitation-to-the-presentation-of-bicos-year-end-report-2025.pdf" class="mfn-generated mfn-primary">Invitation to the presentation of BICO’s Year-end report 2025</a></p></div>